$12.130
-0.050 (-0.41%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
RDY-Prognose durch Analyse ähnlicher Charts
Alphio's RDY stock price prediction model matches the current Dr Reddy's Laboratories Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $12.33 (+1.34%). The 1-week path is $12.62 (+3.66%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich Dr Reddy's Laboratories Ltd-Aktien kaufen?
Dr Reddy's Laboratories Ltd is not a good buy right now due to a recent downgrade from Goldman Sachs, which set a price target of INR 1,075, significantly lower than the current price of $12.18. Additionally, the company's last earnings report showed an EPS of 0.06, which was a 64.71% miss from the expected 0.17, indicating potential ongoing financial struggles. The RSI is currently at 47.072, suggesting the stock is neither overbought nor oversold, but the lack of upward momentum and negative analyst sentiment point to a sell recommendation.
RDY schloss am Monday bei $12.13, nachdem der Kurs -0.41% fallen
Dr Reddy's Laboratories Ltd (RDY) last closed at $12.17, gaining +0.33%. These facts feed the 1-day and 1-week RDY price prediction above.
Analystenkonsens
Dr Reddy's Laboratories Ltd (RDY): 0 Kaufen, 0 Halten, 1 Verkaufen. Ausblick: Strong Sell.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Prognose-Treiber
Die Prognose-Treiber von Dr Reddy's Laboratories Ltd (RDY) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf RDY am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für RDY
Historically the probability of a positive September return for RDY is 47.62%. February offers the highest probability of a positive month at 63.79%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.